XVIVO: US MedTech tariffs with exemption for Pharma as for now - Redeye

Medtech is not exempt from US reciprocal tariffs, unlike Pharma. Regarding specific company exposure, there is likely to be a wide range of exposures to US Medtech tariffs.

Länk till analysen i sin helhet: https://www.redeye.se/research/1092801/xvivo-us-medtech-tariffs-with-exemption-for-pharma-as-for-now?utm_source=finwire&utm_medium=RSS